Principal Financial Group
IBIO icon

Principal Financial Group’s iBio IBIO Stock Holding History

Principal Financial Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-87
Closed -$19K – 2571
2022
Q1 		$19K Sell
87
-3
-3% -$628 ﹤0.01% 2523
2021
Q4 		$24K Sell
90
-32
-26% -$12.2K ﹤0.01% 2507
2021
Q3 		$64K Sell
122
-28
-19% -$17.4K ﹤0.01% 2525
2021
Q2 		$113K Sell
150
-2,062
-93% -$1.5M ﹤0.01% 2523
2021
Q1 		$1.7M Buy
2,212
+165
+8% +$144K ﹤0.01% 1885
2020
Q4 		$1.07M Buy
+2,047
New +$1.67M ﹤0.01% 1931

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Principal Financial Group's IBIO Position: Q2 2022 in Review

Principal Financial Group sold out of iBio (IBIO) in Q2 2022, closing a stake of 87 shares — an estimated $19K sold.

Principal Financial Group first reported a position in IBIO in Q4 2020 and held it in 6 quarters. The position peaked at $1.7M in Q1 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • Principal Financial Group reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 87 iBio shares in Q2 2022, an estimated $19K.
  • Principal Financial Group first reported a position in iBio in Q4 2020 and held it in 6 quarters.
  • Principal Financial Group's iBio position peaked at $1.7M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.